These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21626608)
1. Valuing states from multiple measures on the same visual analogue sale: a feasibility study. Rowen D; Brazier J; Tsuchiya A; Alava MH Health Econ; 2012 Jun; 21(6):715-29. PubMed ID: 21626608 [TBL] [Abstract][Full Text] [Related]
2. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945 [TBL] [Abstract][Full Text] [Related]
3. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660 [TBL] [Abstract][Full Text] [Related]
4. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D. Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194 [TBL] [Abstract][Full Text] [Related]
5. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015 [TBL] [Abstract][Full Text] [Related]
6. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Brazier J; Connell J; Papaioannou D; Mukuria C; Mulhern B; Peasgood T; Jones ML; Paisley S; O'Cathain A; Barkham M; Knapp M; Byford S; Gilbody S; Parry G Health Technol Assess; 2014 May; 18(34):vii-viii, xiii-xxv, 1-188. PubMed ID: 24857402 [TBL] [Abstract][Full Text] [Related]
7. Patient and public preferences for health states associated with AMD. Butt T; Dunbar HM; Morris S; Orr S; Rubin GS Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607 [TBL] [Abstract][Full Text] [Related]
8. Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice. Parker M; Haycox A; Graves J Pharmacoeconomics; 2011 Aug; 29(8):719-30. PubMed ID: 21635017 [TBL] [Abstract][Full Text] [Related]
9. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976 [TBL] [Abstract][Full Text] [Related]
10. Unchained melody: revisiting the estimation of SF-6D values. Craig BM Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242 [TBL] [Abstract][Full Text] [Related]
11. Estimating an exchange rate between the EQ-5D-3L and ASCOT. Stevens K; Brazier J; Rowen D Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464 [TBL] [Abstract][Full Text] [Related]
12. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663 [TBL] [Abstract][Full Text] [Related]
13. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia. Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579 [TBL] [Abstract][Full Text] [Related]
14. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods. Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941 [TBL] [Abstract][Full Text] [Related]
15. A comparison of methods for converting DCE values onto the full health-dead QALY scale. Rowen D; Brazier J; Van Hout B Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621 [TBL] [Abstract][Full Text] [Related]
16. 'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases. Meregaglia M; Whittal A; Nicod E; Drummond M Pharmacoeconomics; 2020 Jun; 38(6):557-574. PubMed ID: 32152892 [TBL] [Abstract][Full Text] [Related]
17. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Whitehurst DG; Norman R; Brazier JE; Viney R Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050 [TBL] [Abstract][Full Text] [Related]
18. Responsiveness of generic health-related quality of life measures in stroke. Pickard AS; Johnson JA; Feeny DH Qual Life Res; 2005 Feb; 14(1):207-19. PubMed ID: 15789955 [TBL] [Abstract][Full Text] [Related]
19. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients. Breheny K; Hollingworth W; Kandiyali R; Dixon P; Loose A; Craggs P; Grzeda M; Sparrow J Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789 [TBL] [Abstract][Full Text] [Related]
20. A review of the psychometric properties of generic utility measures in multiple sclerosis. Kuspinar A; Mayo NE Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]